Hims & Hers Health (HIMS) last issued guidance on February 23, 2026 for Q1 2026. The company guided revenue in the range of $600.00M - $625.00M for the period.

Compared to prior guidance, Hims & Hers Health lowered its revenue forecast from a prior range of $2.70B - $2.90B.

Hims & Hers Health has issued 32 guidance updates between May 9, 2022 and February 23, 2026. During this period, the company raised its outlook 13 times and lowered it 15 times, providing investors with insight into management's evolving expectations.